This was part of Decision Making in Health and Medical Care

Medical treatments for rare diseases: my FDA perspective

Ilan Irony, FDA/CBER

Monday, May 17, 2021

Abstract: Dr. Irony will present on the topic of FDA engagement in assisting the development of treatments for rare diseases, through the use of various regulatory authorities available.